The main studies published so far involve i) specific populations, such as young women with BC [7]; or ii) regions and/or specific gene mutations, with most studies focusing their analysis on the founder mutations at BRCA1/BRCA2 genes [7–13]. This evidence concerns the gene BRCA2 and breast cancer.